Back to search
Smith-Magenis Syndrome (SMS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Smith-Magenis Syndrome (SMS) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Smith-Magenis Syndrome (SMS) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Currently, there is no clinically available genetic-based treatment for RAI1 (Retinoic Acid-Induced 1) -related disorders other than symptomatic management and…
Autism Spectrum Disorders (ASD) are a neurodevelopmental disorder. Their prevalence is estimated at around 0.4% of the general population worldwide. Their early…
This database will be used to better understand the sleep problems of people with SMS. This clinical database will be a part of a larger Smith-Magenis Patient R…
This study will examine how a rare disease called Smith-Magenis syndrome (SMS) affects people and how they change over time. SMS is caused by a small chromosome…
The objective is to develop and test, through an iterative process, an intervention to address and support the development of infants with a confirmed diagnosis…